LD-2 disclosure · 2nd Quarter - Report
ARUP LABORATORIES, INC.
Client
- Name
- ARUP LABORATORIES, INC.
- Description
- Diagnostic testing laboratory
- Location
- Utah · United States of America
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Lab infrastructure related issues
LobbyistsMATT HENKEN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.1666, VITAL Act of 2021, Diagnostic Lab Testing S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Highly skilled visa related issues Public Law 117-58, Infrastructure Investment and Jobs Act
LobbyistsJENNIFER LATOURETTE · ms LESLEE KOCH GILBERT · MATT HENKEN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.1666, VITAL Act of 2021, Diagnostic Lab Testing S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Highly skilled visa related issues Public Law 117-58, Infrastructure Investment and Jobs Act
